These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7791189)

  • 1. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.
    Huong DL; Papo T; Gatfosse M; Frances C; Godeau P; Beaufils H
    J Rheumatol; 1995 Apr; 22(4):791-2. PubMed ID: 7791189
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.
    Endo H; Hosono T; Kondo H
    J Rheumatol; 1994 May; 21(5):864-70. PubMed ID: 8064727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis.
    Casari S; Haeney M; Farrand S; Herrick A
    J Rheumatol; 2002 Dec; 29(12):2666-7. PubMed ID: 12465176
    [No Abstract]   [Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis.
    Akimoto S; Ishikawa O; Tamura T; Miyachi Y
    Br J Dermatol; 1996 Mar; 134(3):407-10. PubMed ID: 8731661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
    Manolova I; Dancheva M
    J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
    [No Abstract]   [Full Text] [Related]  

  • 6. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies.
    Hillis GS; Khan IH; Simpson JG; Rees AJ
    Am J Kidney Dis; 1997 Aug; 30(2):279-81. PubMed ID: 9261042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
    Kamen DL; Wigley FM; Brown AN
    J Rheumatol; 2006 Sep; 33(9):1886-8. PubMed ID: 16832842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of MPO-ANCA positive progressive systemic sclerosis with status epileptics].
    Uriuhara A; Morita S; Yamada K; Masugi J; Yamada H; Hasegawa Y; Yokono K; Kasuga M
    Ryumachi; 1997 Jun; 37(3):483-6. PubMed ID: 9256032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy.
    Villaverde V; Balsa A; Cabezas JA; Fernández-Prada M; Torre A; Mola EM
    Rheumatology (Oxford); 1999 Feb; 38(2):190-1. PubMed ID: 10342639
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies to myeloperoxidase in systemic sclerosis.
    Locke IC; Worrall JG; Leaker B; Black CM; Cambridge G
    J Rheumatol; 1997 Jan; 24(1):86-9. PubMed ID: 9002016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
    Grypiotis P; Cozzi F; Ruffatti A
    J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
    [No Abstract]   [Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
    Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
    Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement].
    Martínez Ara J; Picazo ML; Torre A; Pascual D; Díaz Rodríguez C; Riñón C
    Nefrologia; 2000; 20(4):383-6. PubMed ID: 11039266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
    J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 17. Bronchocentric granulomatosis, acute renal failure, and high titer antineutrophil cytoplasmic antibodies: possible variants of Wegener's granulomatosis.
    Fannin SW; Hagley MT; Seibert JD; Koenig TJ
    J Rheumatol; 1993 Mar; 20(3):507-9. PubMed ID: 8478859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myeloperoxidase antibody(MPO-ANCA) without pathological renal involvement].
    Yamada T; Nakajima H; Tanaka E; Nakajima A; Terai C; Hara M; Kamatani N
    Ryumachi; 2003 Oct; 43(4):690-5. PubMed ID: 14598664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies and clinical subsets: relevance to scleroderma.
    Maddison PJ
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):684-6. PubMed ID: 11020957
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibody associated vasculitis and renal failure in Behçet's disease.
    Khan IH; Catto GR; MacLeod AM
    Nephrol Dial Transplant; 1994; 9(3):332. PubMed ID: 8052448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.